Filing Summary
Registrant and reporting date: The filing identifies the registrant as MultiPlan Corporation, not Claritev Corp. The Form 8-K was filed for an event occurring February 27, 2023, and was signed March 3, 2023.
Business Context and Reporting Period
This is an Item 5.02 Form 8-K concerning the promotion and compensation arrangements of Jeffrey Doctoroff. It does not report quarterly or annual operating results.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating performance metrics.
Material Changes
- Mr. Doctoroff was promoted from Senior Vice President to Executive Vice President while retaining his positions as General Counsel and Secretary.
- Effective February 25, 2023, his annual base salary increased or was established at $405,000, subject to future Compensation Committee adjustments.
- Effective January 1, 2023, his annual bonus target was set at 70% of annual base salary.
- His annual eligibility for equity compensation under the company’s equity incentive plan did not change.
Outlook, Risks, Contingencies, and Unusual Items
- If the company terminates Mr. Doctoroff without “cause,” as defined in the offer letter, he is entitled to nine months of salary continuation.
- The company must also pay or reimburse COBRA premiums through the earlier of 18 months after termination or the date he obtains other employment offering group health benefits.
- The filing does not provide broader business guidance, financial outlook, or risk updates.
Investor Verification Items
- Verify the registrant identity: the filing names MultiPlan Corporation, while the request metadata names Claritev Corp.
- Review Exhibit 10.1, the February 27, 2023 offer letter, for the complete terms and definitions.
- Assess the effect of the revised executive compensation and potential severance and benefits obligations on future compensation expense.
- Confirm that no changes were made to Mr. Doctoroff’s annual equity compensation eligibility.